Category Archives: Non-communicable diseases


Aging Gracefully: Exploring Issues of Particular Importance for Aging American Indians and Alaska Natives

Aging is inevitable.  It happens to all of us, and it is not a homogeneous experience.  It impacts everyone differently and on different timelines.  There are a variety of issues that affect aging populations, such as ever increasing healthcare costs, the depletion of Social Security funds, and the rise of noncommunicable diseases (NCDs). Aging American […]

Read More

Posted in National Healthcare, Non-communicable diseases; Tagged: , , , , .


New litigation challenges Big Soda’s marketing strategy

This blog post was co-authored by Javier Saladich, a Summer Research Intern at the O’Neill Institute. Javier is a third year law student at ESADE Business and Law School in Barcelona, Spain. Last month, two prominent African American pastors and a public health organization sued a major soda manufacturer and soda industry body, alleging that […]

Read More

Posted in Non-communicable diseases; Tagged: , .


How the Built Environment Can Impact your Health

Improving your health can be as simple as choosing to walk to work or to take the stairs instead of the escalator.  However, stairs are not even a viable option in some buildings and for some people it is not feasible to walk or bike to work.  This blog post examines how public health is […]

Read More

Posted in Global Health, Health reform, National Healthcare, Non-communicable diseases; Tagged: , , , , , , , , , , , , .


A TALE OF TWO CITIES: VICTORIES FOR SODA TAXES IN PHILADELPHIA AND SEATTLE

Hanhsi Indy Liu is an SJD candidate at Georgetown University Law Center. Sarah Roache is a Senior Associate at the O’Neill Institute for National and Global Health Law. Any questions or comments on this post can be sent to: hl580@georgetown.edu. Advocates for public health-based soda taxes had two important victories this month: a Pennsylvania appeals […]

Read More

Posted in Non-communicable diseases; Tagged: , , .


Direct to Consumer Genetic Testing: Risks and Opportunities

Accurate genetic testing stands to transform modern medicine by offering effective, personalized treatment. Last week, the U.S. Food and Drug Administration (FDA) authorized marketing of the first direct-to-consumer (DTC) genetic health risk (GHR) tests. Individuals in the US can now purchase DTC tests and gain potentially useful information on their genetic predisposition to 10 diseases […]

Read More

Posted in FDA, Non-communicable diseases;


Archives

Stay Informed

Signup for our mailing list and stay up to date on the latest happenings at The O’Neill Institute

Or sign up for our RSS Feed

The views reflected in this blog are those of the individual authors and do not necessarily represent those of the O’Neill Institute for National and Global Health Law or Georgetown University. This blog is solely informational in nature, and not intended as a substitute for competent legal advice from a licensed and retained attorney in your state or country.

See the full disclaimer and terms of use.